+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Ophthalmic Gene Therapy Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Application

  • PDF Icon

    Report

  • 88 Pages
  • February 2024
  • Region: Global
  • Prof Research
  • ID: 5729080
Description Jump to:

Quick Summary:

In a rapidly developing industry like Ophthalmic Gene Therapy, staying informed and ahead of the curve is essential for business prosperity. This comprehensive report provides a deep dive into the global market size, competitor analysis, regional supply-demand dynamics, and more, painting a clear picture of where the market stands and what could potentially lie ahead.

The report covers key regions including North America, South America, Asia, Pacific, Europe, and MEA, alongside essential markets such as the United States, China, Japan, India, and Brazil. Not only does the report capture the global landscape of Ophthalmic Gene Therapy, it captures relevant information of key competitors and offers a robust SWOT analysis. For those interested in the application segment, particularly Age-Related Macular Degeneration, this report packs crucial insight. Grab this vital tool and leverage in-depth knowledge to guide your strategic decisions.

This report describes the global market size of Ophthalmic Gene Therapy from 2019 to 2023 and its CAGR from 2019 to 2023, and also forecasts its market size to the end of 2029 and its CAGR from 2024 to 2029.

For the geography segment; regional supply, demand, major players, and price is presented from 2019 to 2029.

This report covers the following regions:

  • North America
  • South America
  • Asia & Pacific
  • Europe
  • MEA
The key countries for each region are also included, such as United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.

For the competitor segment, the report includes global key players of Ophthalmic Gene Therapy as well as some small players.

The information for each competitor includes:

  • Company Profile
  • Business Information
  • SWOT Analysis
  • Revenue, Gross Margin and Market Share

Applications Segment

  • Age-Related Macular Degeneration

Companies Covered

  • 4-D Molecular Therapeutics
  • Adverum
  • REGENXBIO
  • Gyroscope Therapeutics
Base Year: 2024
Historical Data: from 2019 to 2023
Forecast Data: from 2024 to 2029


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1 Executive SummaryChapter 2 Abbreviation and Acronyms
Chapter 3 Preface
3.1 Research Scope
3.2 Research Sources
3.2.1 Data Sources
3.2.2 Assumptions
3.3 Research Method
Chapter 4 Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users
Chapter 5 Market Trend Analysis
5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats
5.6 COVID-19 Impact
Chapter 6 Industry Chain Analysis
6.1 Upstream/Suppliers Analysis
6.2 Ophthalmic Gene Therapy Analysis
6.2.1 Technology Analysis
6.2.2 Cost Analysis
6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users
Chapter 7 Latest Market Dynamics
7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics
Chapter 8 Historical and Forecast Ophthalmic Gene Therapy Market in North America (2019-2029)
8.1 Ophthalmic Gene Therapy Market Size
8.2 Ophthalmic Gene Therapy Market by End Use
8.3 Competition by Players/Suppliers
8.4 Ophthalmic Gene Therapy Market Size by Type
8.5 Key Countries Analysis
8.5.1 United States
8.5.2 Canada
8.5.3 Mexico
Chapter 9 Historical and Forecast Ophthalmic Gene Therapy Market in South America (2019-2029)
9.1 Ophthalmic Gene Therapy Market Size
9.2 Ophthalmic Gene Therapy Market by End Use
9.3 Competition by Players/Suppliers
9.4 Ophthalmic Gene Therapy Market Size by Type
9.5 Key Countries Analysis
9.5.1 Brazil
9.5.2 Argentina
9.5.3 Chile
9.5.4 Peru
Chapter 10 Historical and Forecast Ophthalmic Gene Therapy Market in Asia & Pacific (2019-2029)
10.1 Ophthalmic Gene Therapy Market Size
10.2 Ophthalmic Gene Therapy Market by End Use
10.3 Competition by Players/Suppliers
10.4 Ophthalmic Gene Therapy Market Size by Type
10.5 Key Countries Analysis
10.5.1 China
10.5.2 India
10.5.3 Japan
10.5.4 South Korea
10.5.5 Southeast Asia
10.5.6 Australia
Chapter 11 Historical and Forecast Ophthalmic Gene Therapy Market in Europe (2019-2029)
11.1 Ophthalmic Gene Therapy Market Size
11.2 Ophthalmic Gene Therapy Market by End Use
11.3 Competition by Players/Suppliers
11.4 Ophthalmic Gene Therapy Market Size by Type
11.5 Key Countries Analysis
11.5.1 Germany
11.5.2 France
11.5.3 United Kingdom
11.5.4 Italy
11.5.5 Spain
11.5.6 Belgium
11.5.7 Netherlands
11.5.8 Austria
11.5.9 Poland
11.5.10 Russia
Chapter 12 Historical and Forecast Ophthalmic Gene Therapy Market in MEA (2019-2029)
12.1 Ophthalmic Gene Therapy Market Size
12.2 Ophthalmic Gene Therapy Market by End Use
12.3 Competition by Players/Suppliers
12.4 Ophthalmic Gene Therapy Market Size by Type
12.5 Key Countries Analysis
12.5.1 Egypt
12.5.2 Israel
12.5.3 South Africa
12.5.4 Gulf Cooperation Council Countries
12.5.5 Turkey
Chapter 13 Summary For Global Ophthalmic Gene Therapy Market (2019-2024)
13.1 Ophthalmic Gene Therapy Market Size
13.2 Ophthalmic Gene Therapy Market by End Use
13.3 Competition by Players/Suppliers
13.4 Ophthalmic Gene Therapy Market Size by Type
Chapter 14 Global Ophthalmic Gene Therapy Market Forecast (2024-2029)
14.1 Ophthalmic Gene Therapy Market Size Forecast
14.2 Ophthalmic Gene Therapy Application Forecast
14.3 Competition by Players/Suppliers
14.4 Ophthalmic Gene Therapy Type Forecast
Chapter 15 Analysis of Global Key Vendors
15.1 4-D Molecular Therapeutics
15.1.1 Company Profile
15.1.2 Main Business and Ophthalmic Gene Therapy Information
15.1.3 SWOT Analysis of 4-D Molecular Therapeutics
15.1.4 4-D Molecular Therapeutics Ophthalmic Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
15.2 Adverum
15.2.1 Company Profile
15.2.2 Main Business and Ophthalmic Gene Therapy Information
15.2.3 SWOT Analysis of Adverum
15.2.4 Adverum Ophthalmic Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
15.3 REGENXBIO
15.3.1 Company Profile
15.3.2 Main Business and Ophthalmic Gene Therapy Information
15.3.3 SWOT Analysis of REGENXBIO
15.3.4 REGENXBIO Ophthalmic Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
15.4 Gyroscope Therapeutics
15.4.1 Company Profile
15.4.2 Main Business and Ophthalmic Gene Therapy Information
15.4.3 SWOT Analysis of Gyroscope Therapeutics
15.4.4 Gyroscope Therapeutics Ophthalmic Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
List of Tables and Figures
Table Abbreviation and Acronyms
Table Research Scope of Ophthalmic Gene Therapy Report
Table Data Sources of Ophthalmic Gene Therapy Report
Table Major Assumptions of Ophthalmic Gene Therapy Report
Figure Market Size Estimated Method
Figure Major Forecasting Factors
Figure Ophthalmic Gene Therapy Picture
Table Ophthalmic Gene Therapy Classification
Table Ophthalmic Gene Therapy Applications
Table Drivers of Ophthalmic Gene Therapy Market
Table Restraints of Ophthalmic Gene Therapy Market
Table Opportunities of Ophthalmic Gene Therapy Market
Table Threats of Ophthalmic Gene Therapy Market
Table COVID-19 Impact For Ophthalmic Gene Therapy Market
Table Raw Materials Suppliers
Table Different Production Methods of Ophthalmic Gene Therapy
Table Cost Structure Analysis of Ophthalmic Gene Therapy
Table Key End Users
Table Latest News of Ophthalmic Gene Therapy Market
Table Merger and Acquisition
Table Planned/Future Project of Ophthalmic Gene Therapy Market
Table Policy of Ophthalmic Gene Therapy Market
Table 2019-2029 North America Ophthalmic Gene Therapy Market Size
Figure 2019-2029 North America Ophthalmic Gene Therapy Market Size and CAGR
Table 2019-2029 North America Ophthalmic Gene Therapy Market Size by Application
Table 2019-2024 North America Ophthalmic Gene Therapy Key Players Revenue
Table 2019-2024 North America Ophthalmic Gene Therapy Key Players Market Share
Table 2019-2029 North America Ophthalmic Gene Therapy Market Size by Type
Table 2019-2029 United States Ophthalmic Gene Therapy Market Size
Table 2019-2029 Canada Ophthalmic Gene Therapy Market Size
Table 2019-2029 Mexico Ophthalmic Gene Therapy Market Size
Table 2019-2029 South America Ophthalmic Gene Therapy Market Size
Figure 2019-2029 South America Ophthalmic Gene Therapy Market Size and CAGR
Table 2019-2029 South America Ophthalmic Gene Therapy Market Size by Application
Table 2019-2024 South America Ophthalmic Gene Therapy Key Players Revenue
Table 2019-2024 South America Ophthalmic Gene Therapy Key Players Market Share
Table 2019-2029 South America Ophthalmic Gene Therapy Market Size by Type
Table 2019-2029 Brazil Ophthalmic Gene Therapy Market Size
Table 2019-2029 Argentina Ophthalmic Gene Therapy Market Size
Table 2019-2029 Chile Ophthalmic Gene Therapy Market Size
Table 2019-2029 Peru Ophthalmic Gene Therapy Market Size
Table 2019-2029 Asia & Pacific Ophthalmic Gene Therapy Market Size
Figure 2019-2029 Asia & Pacific Ophthalmic Gene Therapy Market Size and CAGR
Table 2019-2029 Asia & Pacific Ophthalmic Gene Therapy Market Size by Application
Table 2019-2024 Asia & Pacific Ophthalmic Gene Therapy Key Players Revenue
Table 2019-2024 Asia & Pacific Ophthalmic Gene Therapy Key Players Market Share
Table 2019-2029 Asia & Pacific Ophthalmic Gene Therapy Market Size by Type
Table 2019-2029 China Ophthalmic Gene Therapy Market Size
Table 2019-2029 India Ophthalmic Gene Therapy Market Size
Table 2019-2029 Japan Ophthalmic Gene Therapy Market Size
Table 2019-2029 South Korea Ophthalmic Gene Therapy Market Size
Table 2019-2029 Southeast Asia Ophthalmic Gene Therapy Market Size
Table 2019-2029 Australia Ophthalmic Gene Therapy Market Size
Table 2019-2029 Europe Ophthalmic Gene Therapy Market Size
Figure 2019-2029 Europe Ophthalmic Gene Therapy Market Size and CAGR
Table 2019-2029 Europe Ophthalmic Gene Therapy Market Size by Application
Table 2019-2024 Europe Ophthalmic Gene Therapy Key Players Revenue
Table 2019-2024 Europe Ophthalmic Gene Therapy Key Players Market Share
Table 2019-2029 Europe Ophthalmic Gene Therapy Market Size by Type
Table 2019-2029 Germany Ophthalmic Gene Therapy Market Size
Table 2019-2029 France Ophthalmic Gene Therapy Market Size
Table 2019-2029 United Kingdom Ophthalmic Gene Therapy Market Size
Table 2019-2029 Italy Ophthalmic Gene Therapy Market Size
Table 2019-2029 Spain Ophthalmic Gene Therapy Market Size
Table 2019-2029 Belgium Ophthalmic Gene Therapy Market Size
Table 2019-2029 Netherlands Ophthalmic Gene Therapy Market Size
Table 2019-2029 Austria Ophthalmic Gene Therapy Market Size
Table 2019-2029 Poland Ophthalmic Gene Therapy Market Size
Table 2019-2029 Russia Ophthalmic Gene Therapy Market Size
Table 2019-2029 MEA Ophthalmic Gene Therapy Market Size
Figure 2019-2029 MEA Ophthalmic Gene Therapy Market Size and CAGR
Table 2019-2029 MEA Ophthalmic Gene Therapy Market Size by Application
Table 2019-2024 MEA Ophthalmic Gene Therapy Key Players Revenue
Table 2019-2024 MEA Ophthalmic Gene Therapy Key Players Market Share
Table 2019-2029 MEA Ophthalmic Gene Therapy Market Size by Type
Table 2019-2029 Egypt Ophthalmic Gene Therapy Market Size
Table 2019-2029 Israel Ophthalmic Gene Therapy Market Size
Table 2019-2029 South Africa Ophthalmic Gene Therapy Market Size
Table 2019-2029 Gulf Cooperation Council Countries Ophthalmic Gene Therapy Market Size
Table 2019-2029 Turkey Ophthalmic Gene Therapy Market Size
Table 2019-2024 Global Ophthalmic Gene Therapy Market Size by Region
Table 2019-2024 Global Ophthalmic Gene Therapy Market Size Share by Region
Table 2019-2024 Global Ophthalmic Gene Therapy Market Size by Application
Table 2019-2024 Global Ophthalmic Gene Therapy Market Share by Application
Table 2019-2024 Global Ophthalmic Gene Therapy Key Vendors Revenue
Figure 2019-2024 Global Ophthalmic Gene Therapy Market Size and Growth Rate
Table 2019-2024 Global Ophthalmic Gene Therapy Key Vendors Market Share
Table 2019-2024 Global Ophthalmic Gene Therapy Market Size by Type
Table 2019-2024 Global Ophthalmic Gene Therapy Market Share by Type
Table 2024-2029 Global Ophthalmic Gene Therapy Market Size by Region
Table 2024-2029 Global Ophthalmic Gene Therapy Market Size Share by Region
Table 2024-2029 Global Ophthalmic Gene Therapy Market Size by Application
Table 2024-2029 Global Ophthalmic Gene Therapy Market Share by Application
Table 2024-2029 Global Ophthalmic Gene Therapy Key Vendors Revenue
Figure 2024-2029 Global Ophthalmic Gene Therapy Market Size and Growth Rate
Table 2024-2029 Global Ophthalmic Gene Therapy Key Vendors Market Share
Table 2024-2029 Global Ophthalmic Gene Therapy Market Size by Type
Table 2024-2029 Ophthalmic Gene Therapy Global Market Share by Type

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • 4-D Molecular Therapeutics
  • Adverum
  • REGENXBIO
  • Gyroscope Therapeutics

Methodology

Loading
LOADING...

Related Topics

Related Reports

AAV vectors in gene therapy - Pipeline Insight, 2024 - Product Image

AAV vectors in gene therapy - Pipeline Insight, 2024

  • Drug Pipelines
  • 398 Pages
  • Global
From
Gene Therapy Global Market Report 2024 - Product Image

Gene Therapy Global Market Report 2024

  • Report
  • 250 Pages
  • Global
From
Gene Therapy Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Product Type - Product Image

Gene Therapy Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Product Type

  • Report
  • 137 Pages
  • Global
From
Cell and Gene Therapy Market and Deals Analysis, 2023: Financings, Partnering, Mergers and Acquisitions, Tech Transfers, IPOs, and Other Deals - Product Image

Cell and Gene Therapy Market and Deals Analysis, 2023: Financings, Partnering, Mergers and Acquisitions, Tech Transfers, IPOs, and Other Deals

  • Report
  • 261 Pages
  • Global
From
Cell and Gene Therapy Global Market Report 2024 - Product Image

Cell and Gene Therapy Global Market Report 2024

  • Report
  • 250 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.